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The adipocyte is like a bank: a place to store excess (caloric) cash in times of plenty, and
from which one can withdraw savings during “lean times.”The β-adrenoceptors (βAR) are
the gateways to this mobilization of fat to be consumed in other tissues. This review dis-
cusses the βAR signaling pathway(s) in white and brown adipocytes. Studies in rodent
models show that brown adipocytes nestled with white fat depots correlate with and are
considered a key enabling factor in resistance to diet-induced obesity. Since it is now rec-
ognized that adult humans have brown adipocytes, knowing the steps in these signaling
pathways may provide the opportunity to manipulate adipocytes to be net consumers of
energy.
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The catecholamines adrenaline and noradrenaline are well known
as the physiological trigger for hydrolyzing stored fat in adipose
tissue so that it can be “burned” as fuel in other organs. Adrena-
line is commonly referred to as the “ﬁght or ﬂight” hormone. This
is because it orchestrates the body’s defensive response for rapid
recruitment of metabolic fuel from adipose tissue lipolysis, as well
as to increase heart rate to enhance tissue perfusion so that organs
such as skeletalmuscle, and the heart itself, can extract, andmetab-
olize that fuel. These catecholamines control fat cell metabolism in
large part through activation of the β-adrenoceptors (βARs). The
βARs are members of the large family of G protein-coupled recep-
tors (GPCRs) that are integral membrane proteins of the plasma
membrane. The three subtypes of βARs (β1AR, β2AR, and β3AR)
are the products of different genes, and adipocytes express all three
subtypes. In the mid-late 1980s the discovery of the β3AR subtype
and selective ligands for this receptor led to a period of intense
interest in this receptor. This was largely because of the powerful
effect of selective β3AR agonists to promote energy expenditure
and weight loss in animal models. However, the relatively poor
preliminary performance of human β3AR agonists in clinical tri-
als (Buemann et al., 2000; Arch, 2002) – and the general belief that
adult humans do not possess brown fat – led to the termination of
most such research programs.
β-Adrenoceptor activation promotes lipolysis of stored triglyc-
eride in both white and brown adipocytes. In brown adipocytes
there is a dense sympathetic nervous system (SNS) innervation
and these fatty acids that are released function as both a fuel source
and activators of the UCP1 protein, which permits mitochondr-
ial respiration without ATP generation (as discussed elsewhere in
this edited volume). Because of this high capacity for uncoupled
oxidative respiration, BAT is capable of consuming considerable
calories through non-shivering thermogenesis (Lean, 1989; Ned-
ergaard et al., 2001). Its rich vasculature allows the dissemination
of this heat to other organs. From detailed studies in rodents
we know that prolonged cold acclimation, which increases SNS
activation of BAT (and WAT), induces the appearance of brown
adipocytes in all adipose depots typically considered to be WAT.
Brown adipocytes can be found within several typical WAT depots
including cervical, axillary, perirenal, periadrenal, and pericardiac
depots (Kortelainen et al., 1993; Cinti, 2005). The increase in these
cells involves branching and increased activity of the sympathetic
nerve ﬁbers within both BAT and WAT (Garofalo et al., 1996;
Giordano et al., 1996; De Matteis et al., 1998; Cinti, 1999, 2005).
The essential role of the SNS in promoting the increased num-
ber and activity of these brown adipocytes is supported by data
from mice deﬁcient in the synthesis of noradrenaline or in βARs
themselves (Thomas and Palmiter, 1997; Bachman et al., 2002;
Jimenez et al., 2002). In these mutants, there is an absence of BAT
that is replaced by WAT, and they tend to be obese. A similar loss
of functioning BAT is observed in animals that have been main-
tained at thermoneutrality, a state in which there is little to no
SNS activity in fat (Cinti, 1999). All together, these results suggest
that β-agonists have the potential to promote postnatal changes
in the WAT/BAT ratio. This could have profound implications, for
example, in inducing weight loss in humans as is already observed
in laboratory animals such as rodents as well as in adult dogs and
rhesus monkeys (Arch et al., 1984; Champigny et al., 1991; Cousin
et al., 1992; Himms-Hagen et al., 1994; Collins et al., 1997; Fisher
et al., 1998). The latter two species, like humans, do not appear to
retain large discrete depots of BAT in adulthood.
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SIGNAL TRANSDUCTION NETWORKS OF βARs IN
ADIPOCYTES
A basic biochemical scheme for the stimulation of adipocyte
metabolism by βARs is presented in Figure 1. In both brown
and white adipocytes activation of βARs sets in motion the clas-
sic signaling paradigm in which the receptor interacts with the
heterotrimeric GTP-binding protein Gs that, in turn, activates
adenylyl cyclase to raise intracellular cAMP levels, the target of
which is the cAMP-dependent protein kinase (PKA). In adipocytes
PKAphosphorylates several proteins that decorate the lipiddroplet
(Brasaemle et al., 2004; Brasaemle, 2007; Bickel et al., 2009) as well
as lipases that catalyze the hydrolysis of triglycerides (Lass et al.,
2011). The interactionof these phosphorylatedproteins at the lipid
droplet surface culminates in the release of free fatty acids and glyc-
erol and their export into the circulation to be consumed as fuel
in other tissues. However, signal transduction through GPCRs,
including the βARs, can consist of multi-component complexes
capable of activating several kinase pathways either concurrently
or sequentially (see Luttrell, 2003 and Reiter and Lefkowitz, 2006
for reviews).
PKA is a well-established downstream agent of the βARs. How-
ever, other kinases are also activated by βARs in adipocytes such
as ERK, p38 MAP, and AMP kinases (Collins et al., 2004; Gau-
thier et al., 2008; Omar et al., 2009). The activation of these other
kinase classes sometimes depends directly upon PKA, while for
others a connection to PKA exists only as a consequence of its
lipid mobilizing effects (Gauthier et al., 2008). In addition, PKA
in adipocytes is largely Type II, denoting its relative sensitivity to
ambient cAMP levels as compared to Type I (Corbin et al., 1975).
In adipocytes PKA is also membrane-anchored through interac-
tion with the A-kinase anchoring proteins (AKAPS; McConnachie
FIGURE 1 | Scheme for βAR signaling cascades controlling lipolysis in
adipocytes. βARs activate adenylyl cyclase through their coupling to the
heterotrimeric Gs, producing cAMP (green dots) from ATP (yellow dots) to
activate the cAMP-dependent protein kinase (PKA), allowing the catalytic
subunits (PKA-C2) to be released from the holoenzyme that is anchored to
the plasma membrane (AKAP). PKA phosphorylates (blue dots) lipases
(HSL: hormone sensitive lipase) and lipid droplet binding proteins such as
perilipins (Peri A; Peri B). Adipose triglyceride lipase (ATGL) is
phosphorylated but not by PKA. The fatty acids released from triglyceride
are chaperoned out of the cell by lipid binding proteins (aP2) and exported
through fatty acid transport proteins (FATP).
et al., 2006). Thus there are spatial aspects to PKA activation to
consider as well. In that regard an interesting new report identi-
ﬁes optic atrophy-1 (OPA1), a protein best known for its role in
mitochondrial “quality control”, as an AKAP targeting PKA to the
lipid droplet to facilitate perilipin phosphorylation and activation
of lipolysis (Pidoux et al., 2011).
G protein-coupled receptors coupled to heterotrimeric Gi
antagonize the activation of adenylyl cyclase in response to βARs.
With the discovery that GPCRs coupled to Gi can also activate
the ERK MAP kinase pathway (Daub et al., 1996; van Biesen
et al., 1996), we now know that the picture is a bit more com-
plex. Another dimension to this signaling is that GPCRs can,
under certain circumstances, couple to more than one G pro-
tein. This is relevant to βAR signaling in adipocytes in that β2AR
was shown to activate ERK following their phosphorylation by
PKA.As shown in Figure 2, this phosphorylation diminishes β2AR
coupling to Gs and increases coupling to Gi (Zamah et al., 2002;
Martin et al., 2004). Figure 2 also shows that this signaling path-
way includes additional phosphorylation events by GPCR kinases
(GRKs), which triggers the binding of β-arrestin (Lefkowitz et al.,
2006): a scaffolding molecule ﬁrst shown to be involved in the
desensitization of β2AR to terminate its activation of adenylyl
cyclase (Lohse et al., 1990). Subsequently, Luttrell et al. (1999)
showed that β-arrestin has broader roles; ﬁrst showing that it
could recruit Src kinase into a complex that leads to ERK acti-
vation through proline-rich regions that bind the SH3-domain of
Src (see Figure 2).
Functionally this aspect of βAR signaling is important for
adipocytes because βAR activation of ERK is responsible for about
20–25% of lipolysis (Greenberg et al., 2001; Robidoux et al.,
2006). β3AR in particular is interesting in this regard because
it can activate both PKA and ERK by interacting with Gs and
Gi interchangeably in the absence of receptor phosphorylation
FIGURE 2 | βARs activate ERK MAPK in addition to PKA: the β2AR
mechanism as an example. Upon catecholamine activation, PKA is
activated (step 1), and phosphorylates the receptor at intracellular sites (red
circles; step 2a). The receptor is also phosphorylated by G protein-coupled
receptor kinase (GRK) at multiple sites in the C-terminus (step 2b). PKA
phosphorylation interdicts interaction with Gs to favor Gi, while GRK
recruits β-arrestin, promoting ERK activation (step 3). β2AR is subject to
rapid desensitization and internalization (step 4), whereupon phosphatases
remove the phosphates and the receptor is recycled back to the plasma
membrane.
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and β-arrestin (Liggett et al., 1993; Soeder et al., 1999). Instead,
we identiﬁed a novel mechanism by which β3AR is able to acti-
vate ERK. As illustrated in Figure 3A, β3AR contains clusters of
proline motifs in the two most important intracellular regions
of a GPCR: the third intracellular loop and the carboxyl termi-
nus. These prolines are arranged in the PXXP motif that serves
as agonist-dependent docking sites for the SH3-domain of Src.
The ability of β3AR to directly recruit Src kinase in adipocytes is
shown in Figure 3B (adapted from Cao et al., 2000, and see leg-
end). The β3AR-selective agonist CL316243 (CL), triggers ERK
activation via the endogenous β3AR in non-transfected (NT )
cells, and in cells transfected with HA-tagged mouse β3AR. In
the presence of pertussis toxin (PTX), ERK activation was abol-
ished, indicating the requirement for signaling through the het-
erotrimeric Gi. Figure 3B shows that Src kinase co-precipitates
with the HA-β3AR, and this interaction is both β3-agonist and
Gi-dependent. As shown further by Cao et al. there are three to
four of these PXXP motifs within all the species homologs of
β3AR, but perturbations of only one or two of these are enough
to eliminate ERK activation (Cao et al., 2000; Kumar et al., 2007).
FIGURE 3 | A unique dual signaling mechanism by β3AR. (A)The receptor
can couple to both Gs and Gi to activate PKA (step 1a) and ERK (step 1b). The
shaded gray arrows point to subsequent downstream cellular effects. (B)
Preadipocytes were transfected or not (NT) with hemagglutinin (HA)-tagged
β3AR and differentiated. (a) Expression of aP2 and β3AR mRNA as a function
of differentiation on the indicated days. Levels of aP2 are maximal by day 4.
Cyclophilin RNA (Cyclo) is the internal control. (b) Phospho-ERK1/2 in cell
lysates in response to the β3AR agonist CL316243 (CL) in the absence or
presence of pertussis toxin (PTX; n =3; mean±SD). (c) Level of c-Src
co-precipitated with β3AR (n =3; mean±SD). (Adapted from Cao et al., 2000).
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These results suggested that there could perhaps be other mole-
cules in addition to Src that might be recruited to the receptor
as part of a larger complex. A proteomic search for proteins that
could be co-immunoprecipitated with the β3AR from adipocytes
in an agonist-dependent manner identiﬁed several proteins that
interact with the receptor and the proline motifs, among which
was the intermediate ﬁlament protein vimentin (Kumar et al.,
2007). Vimentin is a component of the lipid droplet in adipocytes
(Franke et al., 1987), and was found to be required in adipocytes
for both ERK activation and lipolysis (Kumar et al., 2007). Sev-
eral aspects of this mechanism as well as its signiﬁcance remain
incomplete. These include (i) knowledge of the target(s) of ERK
that are responsible for lipolysis; (ii) the mechanism by which
vimentin is recruited to the β3AR, since it does not possess an
SH3 binding domain, and therefore perhaps requires a protein
intermediate; (iii) the relative importance of ERK in lipolysis in
human adipocytes; (iv) what other events might be regulated
by this βAR-ERK pathway in adipocytes, such as the control
of adipose-secreted factors as one example. Finally, the func-
tion of this βAR-activated ERK pathway in brown adipocytes
and the role of insulin in these effects has been partly investi-
gated (Klein et al., 2000; Lindquist et al., 2000; Fasshauer et al.,
2001) but much work remains to be done both mechanisti-
cally and in physiological terms to understand their roles and
impact.
In addition to ERK, other MAPK kinases are also activated
in response to βARs in adipocytes. p38 MAPK is activated by
βARs in white (Moule and Denton, 1998; Mizuno et al., 2002) and
brown adipocytes (Cao et al., 2001), including human adipocytes
(Figure 4). As shown in Figure 5, we showed that p38 MAPK acti-
vation is indirectly dependent on PKA. An interesting aspect of
βAR-dependent activation of MAPKs in adipocytes is that JNK is
not activated by βARs or cAMP (Robidoux et al., 2005). Impor-
tant downstream targets of this pathway in brown adipocytes are
the transcription of the Ucp1 and PGC-1α genes (Cao et al.,
FIGURE 4 | β-agonists increase activation of p38 MAPK in cultured
human subcutaneous adipocytes. (A)Western blot measuring
isoproterenol (Iso) concentration-response for phospho-p38 MAPK (P-p38).
(B)Western blot comparing P-p38 response to 15min treatment with Iso,
EGF and the positive control cell stressor Anisomycin. All samples shown
are independent biological replicates.
2001, 2004). Later work proposed p38 MAPK as one of the
discriminating factors in the ability of certain mouse strains such
as A/J to increase brown adipocyte numbers in WAT during early
postnatal growth and development (Xue et al., 2006). p38 MAPK
has also been implicated as a downstream factor in the reported
permissive property of BMP7 to contribute to brown adipocyte
differentiation (Tseng et al., 2008). If we think about how the
three βARs activate the same pathways, it becomes clear that
although the pathways are the same, the timing of the signaling is
not necessarily identical, and signal strength can also be affected.
For example, β3AR sacriﬁces amplitude of cAMP generation to
gain the ability to generate two signaling pathways simultaneously.
These concepts are illustrated in Figure 6.
FIGURE 5 | βAR activation of thermogenesis through p38 MAPK. Direct
targets of p38 MAPK include peroxisome proliferator-activated
receptor-gamma coactivator-1α (PGC-1α) and ATF-2. These target the genes
for Pgc-1α and Ucp1.The tandem arrows between PKA and the MAPK
module are not yet biochemically deﬁned.
FIGURE 6 | Signaling networks of the βARs in adipocytes. Each of the
three βARs is able to activate similar pathways: PKA, ERK, and p38 MAPK.
However the order and number of steps involved varies, such that β3AR
represents what we term “concurrent” coupling to Gs vs. Gi, vs. the β2AR
type of “processive” coupling. Less is known about the details of β1AR.
Because β1AR also contains one of the PXXP motifs as in β3AR, but it is also
phosphorylated, we have provisionally termed in “mixed-mode” coupling.
The shaded gray arrows point to subsequent downstream cellular effects.
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Mechanistically, the signaling components between PKA and
p38 MAPK are not understood, although we have made some
progress toward this goal. It appears that p38α MAPK, but not
p38β MAPK, is activated in brown adipocytes downstream of
βARs and PKA, and that the immediate upstream kinase appears
to speciﬁcally be MKK3 (Robidoux et al., 2005). In addition,
although this βAR→PKA→ p38 MAPK pathway also exists in
white adipocytes (including human adipocytes) the downstream
functional consequences are as yet unknown. We generated mice
with adipose-speciﬁc deletion of p38α to uncover the role of PKA-
dependent p38α MAPK activation in white adipocytes. In the
absence of p38α in adipocytes, preliminary evidence suggests that
JNK now becomes active, similar to observations made for some
other tissue-speciﬁc deletions of p38α MAPK (Hui et al., 2007;
Perdiguero et al., 2007; Ventura et al., 2007; Wada et al., 2008).
Inappropriate JNK activation that occurs in other metabolic tis-
sues such as muscle, liver, and fat has been associated with insulin
resistance (Vallerie et al., 2008). Therefore, the complete charac-
terization of these mice will hopefully ﬁll in these gaps in our
understanding of the mechanism(s) and physiological interplay
between p38 MAPK and JNK in adipocytes and the mechanisms
of their control.
Within the last couple of years there has been increasing
evidence that AMPK is activated in adipocytes in response to
lipolytic stimuli such as βARs (Hutchinson et al., 2005; Koh
et al., 2007; Mulligan et al., 2007; Gauthier et al., 2008; Omar
et al., 2009). AMPK activation is not necessarily a result of
direct involvement of PKA but appears to be more related to
lipolysis itself and its effect in reducing the net ATP levels
within adipocytes. These ﬁndings suggest that lipolysis results
in the increase in cellular energy consumption and this is
proposed to be due to the stimulation of energy consuming
processes such as fatty acid re-esteriﬁcation and even mitochon-
drial uncoupling (Gauthier et al., 2008; Yehuda-Shnaidman et al.,
2010).
UNCOVERING PATHWAYS THAT SILENCE OR REPRESS
ENERGY EXPENDITURE IN BROWN ADIPOCYTES
We spend much effort trying to understand how to “stimulate”
or “activate” and “turn on” catabolic pathways such as adaptive
thermogenesis in brown adipocytes. However, if there are active
mechanisms of repression, we need to identify them in order to
release the “brake.”Certain targeted gene disruptions in mice that
result in a lean phenotype have provided some clues to such repres-
sive pathways. Someof these genes includep70S6kinase (Umet al.,
2004), estrogen related receptor-α (Luo et al., 2003), co-repressor
RIP140 (Leonardsson et al., 2004), the liver X receptors (LXR;
Kalaany et al., 2005), and others (Dong et al., 2009; Gao et al.,
2009). Although the connections that may exist between these fac-
tors are not clear,mechanistically we have uncovered an interesting
role at least for the nuclear factors LXRα and RIP140 to function
as a regulated repressor complex that blocks βAR-stimulated Ucp1
gene expression (Wang et al., 2008; Collins et al., 2010). Speciﬁ-
cally, LXRα recruits the co-repressor RIP140 to a DR-4 element
in the Ucp1 enhancer adjacent to the PPAR/RXR binding DR-1
motif, leading to suppression of Ucp1 gene transcription. Given
the common target and interaction between LXR and RIP140, we
can link the phenotype of these individual mutations to a com-
mon mechanism. A necessary element for this repression by LXRα
appears to be the availability of an LXR ligand. While the nature
of these ligands and the enzymes that control their production
are still a matter of much debate (Russell, 2000), at least one sug-
gested candidate, cholesterol-25-hydroxylase, is expressed in white
adipocytes at a level 30 times higher than in brown adipocytes
(Wang et al., 2008). Therefore, this potential point of control will
be an important feature to further explore. Since the ability to
expand these reservoirs of “novel” brown adipocytes in vivo, to
mobilize fuel and to activate thermogenesis all depend on the
catecholamine stimulation of βARs, our understanding of the sig-
naling mechanisms of these receptors, and how they themselves
are regulated, will be a key factor in harnessing the capacity for
increasing these “plastic” brown adipocytes.
CONCLUSION
Although much is known about the signal transduction mecha-
nism of βARs, the future ahead is still full of work to be done.
Undoubtedly more surprises will be in store for us as we continue
to uncover the signaling networks that βARs control in adipocytes
and how we might be able to take advantage of this new knowl-
edge to therapeutically intervene in combating the epidemic of
metabolic disease in our midst.
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